QFII三季度新宠曝光 银行担当“压舱石”，高端制造获加仓

Core Insights - QFII continues to favor core A-share assets amid ongoing structural market trends, with a notable focus on high-end manufacturing and tactical increases in defensive assets and sectors aligned with domestic production trends [1][7] QFII Investment Trends - As of October 28, nearly 40 QFII institutions held approximately 119.4 billion yuan in A-shares, reflecting a diversified investment strategy across various sectors [1][8] - QFII has increased holdings in over 500 A-share companies, with significant investments in banking, electrical equipment, building materials, chemicals, software services, machinery, and hardware [3][4] Key Stocks with Increased Holdings - Major stocks with significant QFII increases include: - Nanjing Bank (1.24 million shares by BNP Paribas) - China Xidian (7.285 million shares by JPMorgan Securities) - Other notable stocks include Oriental Yuhong, Baofeng Energy, Huasheng Tiancheng, Hengli Hydraulic, Huazi Technology, and Siyi Electric [4][5][6] Sector Preferences - QFII's top sectors for increased stock holdings include banking, electrical equipment, and computing, with banks attracting attention due to stable dividend yields and improving performance expectations [7][10] - The electrical equipment sector benefits from strong policy support and demand growth driven by energy transition and grid upgrades [7][10] Large Institutional Preferences - Large foreign institutions, such as Goldman Sachs, are diversifying their investments across various sectors, including machinery, hardware, consumer goods, pharmaceuticals, and more [11] - Goldman Sachs holds significant positions in 52 A-share companies, indicating a broad investment strategy [11] Market Outlook - Analysts suggest that the Chinese stock market is entering a more sustainable upward trend, with recommendations for investors to shift from "selling high" to "buying low" strategies [13] - Continued positive sentiment towards Chinese assets is reflected in the strategies of major investment firms [12][13]